Asthma Warnings Not Working Well, FDA Fears As GSK Seeks Expanded LABA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
LABA prescribing patterns haven’t changed despite FDA’s labeling instructions on asthma safety concerns, agency concludes.